Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of cannabidiol in treatment of pain due to symptomatic osteoarthritis of the knee
2019-003591-40Phase 4Completed
- Sponsor
- Medical University of Vienna, University Clinic for Anesthesiology, General
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) and Chronic knee pain comparing Cannabidiol with Placebo (2 arms). Primary endpoint: Change in WOMAC Pain Index. Started Mar 2020; status: completed.
02
Drugs
cannabidiol
03
Conditions
knee osteoarthritis (OA)Chronic knee pain
Beyond the preview
Go deeper on 2019-003591-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003591-40.